Generation and characterization of ErbB2-CAR-engineered cytokine-induced killer cells for the treatment of high-risk soft tissue sarcoma in children-Reference-Cited by-同舟云学术

Generation and characterization of ErbB2-CAR-engineered cytokine-induced killer cells for the treatment of high-risk soft tissue sarcoma in children

Published:2017-08-02 Issue:39 Volume:8 Page:66137-66153
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Merker Michael¹,Pfirrmann Verena¹,Oelsner Sarah¹²,Fulda Simone³⁴⁵,Klingebiel Thomas¹,Wels Winfried S.²,Bader Peter¹,Rettinger Eva¹

Affiliation:

1. Division for Stem Cell Transplantation and Immunology, Department for Children and Adolescents, University Hospital Frankfurt, Goethe University, Frankfurt, Germany

2. Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt, Germany

3. Institute for Experimental Cancer Research in Pediatrics, Goethe University, Frankfurt, Germany

4. German Cancer Consortium (DKTK), Heidelberg, Germany

5. German Cancer Research Center (DKFZ), Heidelberg, Germany

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted immunotherapy and nanomedicine for rhabdomyosarcoma: The way of the future;Medicinal Research Reviews;2024-06-17

2. CAR products from novel sources: a new avenue for the breakthrough in cancer immunotherapy;Frontiers in Immunology;2024-04-11

3. Bioconjugated liquid-like solid enhances characterization of solid tumor - chimeric antigen receptor T cell interactions;Acta Biomaterialia;2023-12

4. CD276-CAR T cells and Dual-CAR T cells targeting CD276/FGFR4 promote rhabdomyosarcoma clearance in orthotopic mouse models;Journal of Experimental & Clinical Cancer Research;2023-11-04

5. CAR T cells recognizing CD276 and Dual-CAR T cells against CD276/FGFR4 promote rhabdomyosarcoma clearance in orthotopic mouse models;2023-09-06